Health Economics of Rubella
Health Economics of Rubella
Congenital rubella syndrome is costly and rubella vaccination programs, including the vaccination of health workers, children, and women has favorable cost-effectiveness, cost-utility, or cost-benefit ratios in high- and middle-income countries.
However additional studies are required to include low-income countries, tackle methodological limitations, establish the efficiency of immunization programs in conjunction with measles immunization, and establish the most efficient rubella vaccination schedule.
Conclusions
Congenital rubella syndrome is costly and rubella vaccination programs, including the vaccination of health workers, children, and women has favorable cost-effectiveness, cost-utility, or cost-benefit ratios in high- and middle-income countries.
However additional studies are required to include low-income countries, tackle methodological limitations, establish the efficiency of immunization programs in conjunction with measles immunization, and establish the most efficient rubella vaccination schedule.